FDA Releases Draft Guidance for Evaluating Antimicrobial New Animal Drugs' Impact on Human Health Bacteria

Summary

The Food and Drug Administration (FDA) has made available a draft guidance document (#152) outlining its approach to assessing the potential microbiological effects of new antimicrobial animal drugs on bacteria of human health concern, as part of the new animal drug application process.